Costs of irritable bowel syndrome in the UK and US

@article{MaxionBergemann2012CostsOI,
  title={Costs of irritable bowel syndrome in the UK and US},
  author={Stefanie Maxion-Bergemann and Frank Thielecke and Florian Abel and Rito Bergemann},
  journal={PharmacoEconomics},
  year={2012},
  volume={24},
  pages={21-37}
}
  • Stefanie Maxion-Bergemann, Frank Thielecke, +1 author Rito Bergemann
  • Published 2012
  • Medicine
  • PharmacoEconomics
  • Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders, with an estimated prevalence rate in the general population of 10–15% in industrialised countries. Although IBS is not a life-threatening disease, it contributes significantly to a large segment of healthcare resource consumption. This review provides an overview of studies addressing the direct and indirect costs of IBS in the US and the UK. A systematic literature search was conducted in MEDLINE… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 184 CITATIONS, ESTIMATED 61% COVERAGE

    Societal costs for irritable bowel syndrome – a population based study

    VIEW 1 EXCERPT
    CITES BACKGROUND

    IBS clinical management in Italy: The AIGO survey.

    • Marco Soncini, Cristina Stasi, +8 authors Massimo Bellini
    • Medicine
    • Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
    • 2019

    Diagnosis of irritable bowel syndrome: what are we missing?

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.

    FILTER CITATIONS BY YEAR

    2008
    2020

    CITATION STATISTICS

    • 5 Highly Influenced Citations

    • Averaged 8 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 47 REFERENCES

    Clinical economics review: irritable bowel syndrome.

    The economic burden of irritable bowel syndrome in Canada.

    Diagnosis and care of irritable bowel syndrome in a community-based population.

    VIEW 2 EXCERPTS

    A population study on irritable bowel syndrome and mental health.

    VIEW 4 EXCERPTS
    HIGHLY INFLUENTIAL

    Irritable Bowel Syndrome: Update on Pathogenesis and Management

    VIEW 17 EXCERPTS
    HIGHLY INFLUENTIAL